title: Clinical utility of the Covidien Closure Fast™ Endovenous Radiofrequency Ablation Catheter.
abstract: The Closure Fast™ Endovenous Radiofrequency Ablation Catheter is the latest version of a minimally invasive system for the treatment of patients with superficial venous disease. The Closure Fast™ catheter heats the vein wall to 120°C, causing denaturation of the collagen of the vein wall and contraction of the vessel such that no blood can flow through it. Nearly one million systems have been sold since the product was launched. Many, if not all, patients can be treated under local anesthesia with the Closure Fast™ catheter. Duplex ultrasound reports occlusion rates for the treated vein of 94%-98% at 1 year and 85%-93% at 3 years. The system produces average postoperative pain scores of less than 2 out of 10 on a visual analog score. In the first postoperative week, 76% of patients do not require analgesia. Some 45% of patients return to normal activity on the first postoperative day. Serious complications appear to be rare following the Closure Fast™ procedure. Transient paresthesia occurs in 0.2% of cases, thrombophlebitis in 1%-10%, and thromboembolic events in up to 1.4%, mainly heat-induced thrombosis. Closure Fast™ adds significant costs to treating superficial venous disease but studies have shown it to be cost-effective when used in an office setting.
authors.affiliation: University College Hospital Medical School, London, UK.
authors.forename: Simon A
authors.initials: SA
authors.lastname: Braithwaite
authors.affiliation: Department of Cardiovascular Medicine, University of Nottingham, Nottingham, UK.
authors.forename: Bruce D
authors.initials: BD
authors.lastname: Braithwaite
keywords: Closure Fast; Endovenous Radiofrequency Ablation Catheter; catheter